Form 4 for OTLK Outlook Therapeutics, Inc.
Accepted 2021-12-02 00:00:00 ET · period of report 2021-12-02 · accession 0001209191-21-067644 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-02 | 2021-12-02 | OTLK | TRENARY C RUSSELL III | CEO, Pres, Dir | P - Purchase | $1.40 | +10.0K | 10.0K | New | +$14.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-02 | P | A | 10,000 | $1.40 | 10,000 | D | — | — |